Stay updated on Pembrolizumab in MSI Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new revision tag, v3.4.1, was added to the history, replacing v3.4.0, which is a minor update with no changes to study data or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:32:06.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Non-significant UI updates include showing the glossary option, color-coded change indicators and revision labeling (v3.4.0 replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-01-28T21:05:45.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 to the record history. Removed Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T04:05:56.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.3.3, was added to the record history. The HHS Vulnerability Disclosure and Revision: v3.3.2 elements were removed from the footer; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:05:31.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2; Removed Revision: v3.2.0 from the history.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:47.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A site-wide government funding notice banner appears, indicating that information may not be up to date and that operations may be affected; it directs users to cc.nih.gov for operating status and opm.gov for updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-18T07:14:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.